HUP0401803A2 - Leukocita-inaktiváló modul - Google Patents
Leukocita-inaktiváló modulInfo
- Publication number
- HUP0401803A2 HUP0401803A2 HU0401803A HUP0401803A HUP0401803A2 HU P0401803 A2 HUP0401803 A2 HU P0401803A2 HU 0401803 A HU0401803 A HU 0401803A HU P0401803 A HUP0401803 A HU P0401803A HU P0401803 A2 HUP0401803 A2 HU P0401803A2
- Authority
- HU
- Hungary
- Prior art keywords
- leukocyte
- module
- carrier
- leukocytes
- module according
- Prior art date
Links
- 210000000265 leukocyte Anatomy 0.000 title abstract 4
- 230000002779 inactivation Effects 0.000 title 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10147638A DE10147638B4 (de) | 2001-09-27 | 2001-09-27 | Leukozyten-Inaktivierungs-Modul (LIM) |
| PCT/DE2002/003466 WO2003031473A1 (de) | 2001-09-27 | 2002-09-16 | Leukozyten-inaktivierungs-modul (lim) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0401803A2 true HUP0401803A2 (hu) | 2004-11-29 |
Family
ID=7700470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401803A HUP0401803A2 (hu) | 2001-09-27 | 2002-09-16 | Leukocita-inaktiváló modul |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20040241171A1 (de) |
| EP (1) | EP1430085B1 (de) |
| JP (1) | JP5503826B2 (de) |
| CN (1) | CN100346822C (de) |
| AT (1) | ATE438661T1 (de) |
| BR (1) | BR0212816A (de) |
| CA (1) | CA2461900A1 (de) |
| DE (4) | DE20121877U1 (de) |
| HU (1) | HUP0401803A2 (de) |
| MX (1) | MXPA04002736A (de) |
| NO (1) | NO20041682L (de) |
| PL (1) | PL368596A1 (de) |
| RU (1) | RU2327490C2 (de) |
| WO (1) | WO2003031473A1 (de) |
| ZA (1) | ZA200402205B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE20121877U1 (de) | 2001-09-27 | 2003-09-18 | Leukocare Gmbh | Leukozyten-Inaktivierungs-Modul (LIM) |
| US20100306144A1 (en) * | 2009-06-02 | 2010-12-02 | Scholz Martin B | System and method for classifying information |
| JP6773217B2 (ja) * | 2017-04-28 | 2020-10-21 | ヤマハ株式会社 | 受信装置及び信号伝送システム |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2927942B2 (ja) * | 1989-01-27 | 1999-07-28 | オーストラリアン メンブレイン アンド バイオテクノロジィ リサーチ インスティチュート | 受容体膜およびイオノホアのゲーテイング |
| DE69119683T2 (de) * | 1990-07-27 | 1996-10-02 | Pall Corp | Filtereinrichtung zur Entfernung von Leukozyten und Methode zur Verwendung |
| US5639376A (en) * | 1994-01-10 | 1997-06-17 | Hemasure, Inc. | Process for simultaneously removing leukocytes and methylene blue from plasma |
| WO1995018665A1 (en) * | 1994-01-10 | 1995-07-13 | Hemasure, Inc. | Device and process for removing leukocytes and viral inactivating agents from blood |
| JPH08173528A (ja) * | 1994-12-26 | 1996-07-09 | Terumo Corp | 血液処理システム |
| WO1997012632A1 (en) * | 1995-10-05 | 1997-04-10 | Tkb Associates Limited Partnership | Methods for treatment of diseases associated with a deficiency of fas ligand activity |
| AU2674097A (en) * | 1996-04-17 | 1997-11-07 | Cytotherapeutics, Inc. | Method and device for delivery of apoptosis-inducing molecules |
| JPH1076004A (ja) * | 1996-09-05 | 1998-03-24 | Kanegafuchi Chem Ind Co Ltd | 体液処理用吸着材及び体液処理用吸着器 |
| WO1998046242A1 (en) * | 1997-04-11 | 1998-10-22 | Stanford University | Treatment of cancer by the administration of fas ligand expressing non-tumorigenic cells |
| US6204055B1 (en) * | 1999-04-12 | 2001-03-20 | Isis Pharmaceuticals, Inc. | Antisense inhibition of Fas mediated signaling |
| DE60027863T2 (de) * | 1999-03-17 | 2006-12-07 | Jimro Co., Ltd., Takasaki | Apherese von leukozyten aus blut zur behandlung von hiv |
| JP2001103977A (ja) * | 1999-10-12 | 2001-04-17 | National Institute Of Animal Health | ブタＦａｓリガンドの構造遺伝子 |
| US6797514B2 (en) * | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| DE20121877U1 (de) | 2001-09-27 | 2003-09-18 | Leukocare Gmbh | Leukozyten-Inaktivierungs-Modul (LIM) |
-
2001
- 2001-09-27 DE DE20121877U patent/DE20121877U1/de not_active Expired - Lifetime
- 2001-09-27 DE DE10147638A patent/DE10147638B4/de not_active Expired - Fee Related
-
2002
- 2002-09-16 DE DE50213747T patent/DE50213747D1/de not_active Expired - Lifetime
- 2002-09-16 MX MXPA04002736A patent/MXPA04002736A/es active IP Right Grant
- 2002-09-16 BR BR0212816-0A patent/BR0212816A/pt not_active IP Right Cessation
- 2002-09-16 CN CNB028188330A patent/CN100346822C/zh not_active Expired - Fee Related
- 2002-09-16 PL PL02368596A patent/PL368596A1/xx not_active Application Discontinuation
- 2002-09-16 US US10/489,831 patent/US20040241171A1/en not_active Abandoned
- 2002-09-16 CA CA002461900A patent/CA2461900A1/en not_active Abandoned
- 2002-09-16 JP JP2003534455A patent/JP5503826B2/ja not_active Expired - Fee Related
- 2002-09-16 RU RU2004112762/15A patent/RU2327490C2/ru not_active IP Right Cessation
- 2002-09-16 WO PCT/DE2002/003466 patent/WO2003031473A1/de active Application Filing
- 2002-09-16 AT AT02782679T patent/ATE438661T1/de not_active IP Right Cessation
- 2002-09-16 DE DE10294578T patent/DE10294578D2/de not_active Expired - Fee Related
- 2002-09-16 EP EP02782679A patent/EP1430085B1/de not_active Expired - Lifetime
- 2002-09-16 HU HU0401803A patent/HUP0401803A2/hu unknown
-
2004
- 2004-03-19 ZA ZA200402205A patent/ZA200402205B/en unknown
- 2004-04-26 NO NO20041682A patent/NO20041682L/no not_active Application Discontinuation
-
2008
- 2008-05-02 US US12/114,349 patent/US7850969B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005507908A (ja) | 2005-03-24 |
| DE10147638B4 (de) | 2004-05-27 |
| US20080292643A1 (en) | 2008-11-27 |
| DE10294578D2 (de) | 2004-08-26 |
| MXPA04002736A (es) | 2005-09-08 |
| PL368596A1 (en) | 2005-04-04 |
| CN1558915A (zh) | 2004-12-29 |
| BR0212816A (pt) | 2004-10-05 |
| DE10147638A1 (de) | 2003-04-17 |
| NO20041682L (no) | 2004-04-26 |
| CN100346822C (zh) | 2007-11-07 |
| US20040241171A1 (en) | 2004-12-02 |
| ATE438661T1 (de) | 2009-08-15 |
| DE50213747D1 (de) | 2009-09-17 |
| ZA200402205B (en) | 2004-08-16 |
| CA2461900A1 (en) | 2003-04-17 |
| WO2003031473A1 (de) | 2003-04-17 |
| DE20121877U1 (de) | 2003-09-18 |
| EP1430085B1 (de) | 2009-08-05 |
| US7850969B2 (en) | 2010-12-14 |
| JP5503826B2 (ja) | 2014-05-28 |
| EP1430085A1 (de) | 2004-06-23 |
| RU2327490C2 (ru) | 2008-06-27 |
| RU2004112762A (ru) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1155618C (zh) | 聚乙二醇-干扰素结合物 | |
| ATE262336T1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
| DE60325404D1 (de) | Gerät zur bestimmung der dialyse-effizienz | |
| AU2001272735A1 (en) | Novel physiologically active peptide and use thereof | |
| EP1541193A4 (de) | MEDIZINISCHES BEHANDLUNGSSYSTEM UNTER VERWENDUNG EINES BIOLOGISCHEN REGULIERUNGSFUNKTIONSVERûNDERERS, SCHRITTMACHERSYSTEM AUF BASIS DES MEDIZINISCHEN BEHANDLUNGSSYSTEMS, BLUTDRUCKREGULIERSYSTEM UND SYSTEM ZUR BEHANDLUNG VON HERZKRANKHEITEN | |
| ATE349965T1 (de) | Verfahren zum verbessern von orthodontische behandlungen | |
| ATE292979T1 (de) | Verwendung von aktiviertem protein-c zur behandlung überschiessender blutgerinnung bei sepsis | |
| WO2004099906A3 (en) | Interactive unified workstation for benchmarking and care planning | |
| HK1177465A1 (zh) | 具有延長的體內半衰期的生理學活性多肽綴合物 | |
| CA2376497A1 (fr) | Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale | |
| DE60016668D1 (de) | Verfahren zur Behandlung von Kolostrum | |
| EP2000160A3 (de) | Verfahren und Vorrichtungen zur Bestimmung der Dialyseeffizienz | |
| ES2073425T3 (es) | Una nueva glicoproteina de tipo trombomodulina susceptible de ser obtenida a partir de la orina. | |
| HUP0401803A2 (hu) | Leukocita-inaktiváló modul | |
| EP2261251A3 (de) | Verfahren zur Herstellung von einer modifizierten Hämoglobinlösung | |
| ATE409028T1 (de) | Arzneien zur behandlung von nervenerkrankungen | |
| FR2725990B1 (fr) | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux | |
| HUP0401188A2 (hu) | Hiperelágazásos amilopektin sebészeti, gyógyító vagy diagnosztikai eljárásokban emlősöknél való alkalmazásra, különösen plazmatérfogat-növelőként | |
| ATE246923T1 (de) | Dfmo und taxol zur behandlung bzw. vorbeugung von brustkrebs | |
| MXPA04001986A (es) | Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad. | |
| RS92404A (en) | Use of a mare's milk concentrate dried on a highly-dispersed biologically inert matrix | |
| ATE265225T1 (de) | Pharmazeutische präparation, enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen | |
| DE69915848D1 (de) | Verwendung von neohesperidin dc zur herstellung eines medikaments zur vorbeugung bzw. behandlung von krankheiten aufgrund erhoehter blutfettwerte | |
| ATE228362T1 (de) | Verwendung eines retinoidids zur in vivo erhöhung der entkopplung des ucp2 proteins | |
| DE69813354D1 (de) | Mittel zur Behandlung von Herzkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |